Why are Smart Women Waiting Until the Onset of Menopause to Try to Have Kids?
By Miriam Zoll,
PBS
| 05. 27. 2014
In a recent PBS “To the Contrary”show about the infertility industry, host Bonnie Erbe` asked: Why did Miriam Zoll wait until age 40 to try to become a mother?
Here is Zoll’s response.
Over the last four decades, we emancipated daughters of America have been taught that we have the power to control our destinies. Programs like the Ms. Foundation for Women’s original “Take Our Daughters To Work Day,” which I helped co-produce, reinforced the notion that we could grow up to be just about anything––from astronauts to doctors, to lawyers or plumbers. With abortion and contraceptives legally accessible, we believed from an early age that we could control our reproduction, too. If the Pill could help us prevent unwanted pregnancy, surely we could just as easily manifest a wanted pregnancy whenever we were ready. If we encountered obstacles, well, there was always reproductive medicine like in-vitro fertilization (I.V.F.) to save the day.
When it came to motherhood, from the late 1990s onward, rumors like “40 is the new 30” began to spread like wildfire among a small demographic...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026